Bendamustine and pneumocystis pneumonia: A systematic review

BACKGROUND: Bendamustine, a bifunctional mechlorethamine alkylating agent, is used in the treatment of patients with hematologic malignancies. Myelosuppression and cytotoxic effect arises quite often after bendamustine treatment. To date, there have been no recommendations for routine chemoprophylax...

Descripción completa

Detalles Bibliográficos
Autores principales: Hakamifard, Atousa, Mardani, Masoud, Nasiri, Mohammad Javad, Gholipur‐Shahraki, Tahereh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059183/
https://www.ncbi.nlm.nih.gov/pubmed/35509412
http://dx.doi.org/10.1002/hsr2.610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059183/
https://www.ncbi.nlm.nih.gov/pubmed/35509412
http://dx.doi.org/10.1002/hsr2.610

Ejemplares similares